Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung
Condition(s) studied
Investigational drug(s) / intervention(s)
Small RNA-based lung cancer assay: At study enrollment, a blood sample is collected prior to any invasive diagnostic procedure or treatment. A small RNA-based lung cancer assay is performed on the collected blood sample for research purposes. Assay results are not returned to participants or investigators and are not used for clinical decision-making.
Study summary
2,000 individuals, aged 50-80 who have received a lung-RADS category 3 or 4 result on a LDCT screening study and who are scheduled for follow-up diagnostic imaging study, biopsy, clinical consultation or surgical appointment at one of the participating hospitals.
Eligibility
Primary outcome measure(s)
- Primary Objective — 1 year
The study is a prospective, longitudinal, observational study to evaluate the performance of a novel diagnostic test for early-stage lung cancer. The primary endpoint is to detect the presence or absence of lung cancer, as determined by all follow-up imaging, and pathological data obtained throughout the duration of the study.
Trial sites (11)
| Facility | City | Region | Status |
|---|---|---|---|
| Northside Hospital | Atlanta | Georgia | |
| Our Lady of the Lake Regional Medical Center | Baton Rouge | Louisiana | |
| Brigham and Women's Hospital | Boston | Massachusetts | |
| Mass General Hospital | Boston | Massachusetts | |
| UMass Chan Medical School/UMass Memorial Health | Worcester | Massachusetts | |
| Henry Ford Health | Detroit | Michigan | |
| New York Health + Elmhurst Hospitals | Queens | New York | |
| Jacobi Medical Center | The Bronx | New York | |
| Clinical Research Associates of Central PA | DuBois | Pennsylvania | |
| Baptist Hospitals of Southeast Texas | Beaumont | Texas | |
| University Of Utah Health | Salt Lake City | Utah |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05987189 on ClinicalTrials.gov ↗ ← All trials in the USA